世界の尿沈殿物検査市場 – 業界動向と2030年までの予測

尿沈渣検査市場の分析と規模

尿沈渣検査を伴う尿顕微鏡検査は、腎臓専門医にとって失われた技術になりつつあります。尿沈渣分析は、腎臓学における伝統的な診断テストの 1 つです。高齢者人口の増加は市場の成長を押し上げる重要な要因であり、ヘルスケアの拡大と手動プロセスから自動化への段階的な移行、および完全な尿検査に対する臨床医の傾向の高まりは、市場を押し上げる主な要因です。

Data Bridge Market Research の分析によると、尿沈殿物検査市場は 2022 年に 1 兆 6,362 億米ドルと評価され、2030 年までに 2 兆 6,276 億米ドルに達し、2023 年から 2030 年にかけて 6.10% の CAGR で成長する見込みです。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Research がまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

尿沈殿物検査市場の範囲とセグメンテーション  

Market Definition

Sediment in the urine are the possible result from kidney infection, urinary tract infection, bladder infection, vaginal bacteria, yeast infections in men and women, kidney stones, prostatitis, and parasites. Sediment has been associated with bone mineral loss after spinal cord injury. Urine smear test is used to look for visible components in the urine such as white blood cells, epithelial cells, red blood cells, various types of cylinders, crystals.

Urine Sediment Testing Market Dynamics

Drivers

• Growing CVD Cases

The high occurrence of cardiovascular disease is anticipated to increase the growth of the market in the region. According to the Centers for Disease Control and Prevention, in every 34 seconds, one person dies due to CVD in the U.S. Furthermore, around 697,000 people in the U.S. died from heart disease in 2020, which was 1 in every 5 deaths. Additionally, the wide easy availability of better medical facilities, supported by the favourable medical policies are projected to increase the market growth in the region.

• Rise in Product Approvals

Increase in approvals and the launch of new instruments for urine sediment testing is anticipated to boost the market growth. For instance, Bio-Rad Laboratories, Inc. launched Quantify Advanced Control Instrument in January 2022, to monitor the precision urinalysis test procedure in clinical labs. This instrument improved the effectiveness of the laboratory’s statistical process control and demand for products in the upcoming years.

Opportunities

• Increasing Cases of Diabetes

As per the data by the International Diabetes Federation (IDF), in 2021, around 537 million adults are surviving with diabetes. The total number of people suffering from diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. 3 in 4 adults with diabetes live in low- and middle-income countries. Therefore, growing number of diabetes patients globally is expected to be a prime factor to boost the growth of the global market.

• Increased Screening Programs

Various screening programs are undertaken by governments for the early detection of diseases such as urinary and renal disorders. For instance, about 12,497 students of primary and secondary schools from Pingyang, Cangnan, and Yongjia in Wenzhou, China were screened for urinalysis under school urinary analysis programs. The urine abnormalities were observed in primary school students with a detection rate of 36% and 95% in secondary school students. The increasing number of such programs is projected to boost the demand for urinalysis tests.

Restraints/Challenges

• Increased Cost of Testing Methods

The surging cost of these sedimentation techniques are acting as a limit in the market growth. Not all the testing instruments can be afforded by the lower economic group; thus, it can prevent them from availing these instruments despite being so useful.

This urine sediment testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urine sediment testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Urine Sediment Testing Market Scope

The urine sediment testing market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type  

• Fully Automatic Urine Sediment Analyzers
• Semi -Automatic Urine Sediment Analyzers

 Application

• Urinary Tract Infections
• Diabetes
• Kidney Diseases
• Hypertension
• Others

End User

• Hospital
• Diagnostics Centers
• Clinics
• Ambulatory Surgical Centers
• Educational Institutes,
• Others

Urine Sediment Testing Market Regional Analysis/Insights

The urine sediment testing market is analyzed and market size insights and trends are provided by product type, application and end-user as referenced above.

The countries covered in the urine sediment testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the urine sediment testing market because of the growing incidence of diabetes, increasing per capita health care spending, and growing adoption of new and advanced technologies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the increasing number of diagnostic centers and pathological laboratories, increasing health care awareness among the people and growing medical tourism.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The urine sediment testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for urine sediment testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the urine sediment testing market. The data is available for historic period 2011-2021.

Competitive Landscape and Urine Sediment Testing Market Share Analysis

The urine sediment testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urine sediment testing market.

Some of the major players operating in the urine sediment testing market are:

• Medtronic (Ireland)
• Abbott (U.S.)
• Siemens Healthcare GmbH (Germany)
• サーモフィッシャーサイエンティフィック株式会社（米国）
• ゼネラル・エレクトリック（米国）
• BD（米国）
• バイオ・ラッド・ラボラトリーズ社（米国）
• シスメックス株式会社（米国）
• F. ホフマン・ラ・ロシュ社（スイス）
• カーディナルヘルス（米国）
• ボストン・サイエンティフィック・コーポレーション（米国）
• ベックマン・コールター社（米国）。
• ACON Laboratories, Inc (米国)
• BioMaxima SA (ポーランド)
• クイデルコーポレーション（米国）
• メトロポリス ヘルスケア リミテッド インド (インド)
• LalPathLabs.com (インド)
• トリニティ・バイオテック（アイルランド）

SKU-59115